173 related articles for article (PubMed ID: 36046056)
1. Construction of a Prognostic Nomogram Based on Autophagy-Related Genes for Children With Neuroblastoma.
Ye G; Wang Y
Evol Bioinform Online; 2022; 18():11769343221120960. PubMed ID: 36046056
[TBL] [Abstract][Full Text] [Related]
2. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
4. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
Wang J; Meng X; Chen K; Feng J
Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
[TBL] [Abstract][Full Text] [Related]
5. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
Meng X; Li H; Fang E; Feng J; Zhao X
Front Oncol; 2020; 10():1411. PubMed ID: 32974147
[No Abstract] [Full Text] [Related]
7. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
Yan C; Liu Q; Jia R
Front Oncol; 2022; 12():829045. PubMed ID: 35186763
[TBL] [Abstract][Full Text] [Related]
8. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
Xia Y; Li X; Tian X; Zhao Q
Front Mol Biosci; 2021; 8():769661. PubMed ID: 34950701
[No Abstract] [Full Text] [Related]
10. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
Front Oncol; 2020; 10():558596. PubMed ID: 33178587
[TBL] [Abstract][Full Text] [Related]
13. A Novel Online Nomogram Established with Five Features before Surgical Resection for Predicating Prognosis of Neuroblastoma Children: A Population-Based Study.
Zhou Y; Gao J
Technol Cancer Res Treat; 2023; 22():15330338221145141. PubMed ID: 36604997
[No Abstract] [Full Text] [Related]
14. [A comprehensive analysis of potential prognostic biomarkers for MYCN-amplified neuroblastoma].
Fan X; Lu HT; Hou L; Zhang L; Yang BY; Chen WM; Zhang HY; Chen X; Li FJ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):262-268. PubMed ID: 32204764
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
[No Abstract] [Full Text] [Related]
16. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
17. A novel nomogram for predicting post-recurrence survival in recurrent neuroblastoma patients.
Chen WM; Fang YY; Lin P; Bai JX; Fang YF; Zhang B
Am J Cancer Res; 2023; 13(6):2254-2268. PubMed ID: 37424797
[TBL] [Abstract][Full Text] [Related]
18. A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.
Li C; Yuan Q; Xu G; Yang Q; Hou J; Zheng L; Wu G
World J Surg Oncol; 2022 Apr; 20(1):129. PubMed ID: 35459137
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas.
Li X; Huang Z; Zhu L; Yu F; Feng M; Gu A; Jiang J; Wang G; Huang D
Front Genet; 2022; 13():905751. PubMed ID: 35923699
[No Abstract] [Full Text] [Related]
20. Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets.
Zhong X; Tao Y; Chang J; Zhang Y; Zhang H; Wang L; Liu Y
Front Oncol; 2021; 11():631546. PubMed ID: 33767996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]